# Raptim Research Pvt. Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/raptim-research-pvt-ltd/e9b524cf-a459-4a4d-9ac3-2198443949e2

> Inspection records and compliance data for Raptim Research Pvt. Ltd. in Navi Mumbai, None. Access full analysis and detailed observations.

---

## Details

- Name: Raptim Research Pvt. Ltd.
- FEI Number: 3007267856
- City: Navi Mumbai
- State: None
- Country Name: India
- Address Line 1: A - 242, M.I.D.C., T.T.C. Industrial Area, Mahape
- Zip Code: None
- Business Operations: CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING

## Related Documents

- [483 - Raptim Research Pvt. Ltd. - 2025-07-25](https://www.keypedia.com/records/483/raptim-research-pvt-ltd/9a59b441-19a3-4c46-9f3e-474767219e35) — source: FDA, date: July 25, 2025
- [FDA Inspection 1281156 - Raptim Research Pvt. Ltd. - 2025-07-25](https://www.keypedia.com/records/fda_inspections/raptim-research-pvt-ltd/a6c38e0a-c16d-4dd0-8912-b1621372974f) — source: FDA, date: July 25, 2025
- [FDA Inspection 1281109 - Raptim Research Pvt. Ltd. - 2025-07-25](https://www.keypedia.com/records/fda_inspections/raptim-research-pvt-ltd/96bc8288-685f-4d5c-8755-2f6f6205fcc2) — source: FDA, date: July 25, 2025
- [FDA Inspection 1211275 - Raptim Research Pvt. Ltd. - 2023-04-28](https://www.keypedia.com/records/fda_inspections/raptim-research-pvt-ltd/1c08f6f9-7cc3-4e72-a9ad-e7e5876d600f) — classification: Official Action Indicated (OAI), source: FDA, date: April 28, 2023
- [483 - Raptim Research Pvt. Ltd. - 2023-04-24](https://www.keypedia.com/records/483/raptim-research-pvt-ltd/2d6ad079-7dca-492c-bb02-f60d75c4546a) — source: FDA, date: April 24, 2023
- [FDA Inspection 1181097 - Raptim Research Pvt. Ltd. - 2022-09-14](https://www.keypedia.com/records/fda_inspections/raptim-research-pvt-ltd/c1ef7494-2983-4161-8cf2-e820fbfc872a) — classification: No Action Indicated (NAI), source: FDA, date: September 14, 2022
- [FDA Inspection 1110477 - Raptim Research Pvt. Ltd. - 2019-09-19](https://www.keypedia.com/records/fda_inspections/raptim-research-pvt-ltd/50c6caa1-e12e-4d9c-865c-cc4d4fdb9287) — classification: No Action Indicated (NAI), source: FDA, date: September 19, 2019
- [FDA Inspection 1097252 - Raptim Research Pvt. Ltd. - 2019-05-29](https://www.keypedia.com/records/fda_inspections/raptim-research-pvt-ltd/87a25308-d5e5-4f6b-9c49-53e4b36f722a) — classification: No Action Indicated (NAI), source: FDA, date: May 29, 2019
- [FDA Inspection 1092649 - Raptim Research Pvt. Ltd. - 2019-03-22](https://www.keypedia.com/records/fda_inspections/raptim-research-pvt-ltd/fb156f41-91ac-4088-85ff-7e4b5cbf4a22) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 22, 2019

## Related Companies

- [Milupa GmbH](https://www.keypedia.com/companies/milupa-gmbh/a406d6b0-df46-4822-8cfb-732831ba1f7c)
- [McGuff Pharmaceuticals, Inc.](https://www.keypedia.com/companies/mcguff-pharmaceuticals-inc/15443041-ed2c-4d7b-8313-9c85fa0f7bc6)
- [WHPM Inc.](https://www.keypedia.com/companies/whpm-inc/713384b0-f0ac-4ea2-8216-fc8b0910359b)
- [AJES Pharmaceuticals, LLC](https://www.keypedia.com/companies/ajes-pharmaceuticals-llc/4cf8708e-38cc-444a-84c3-5dde5f13721e)
- [Transdermal Cap Inc.](https://www.keypedia.com/companies/transdermal-cap-inc/04de6863-f166-4f39-af50-2e3af20c851d)
- [Corcept Therapeutics Incorporated](https://www.keypedia.com/companies/corcept-therapeutics-incorporated/9f3284cd-b285-4408-818e-19b78043d2e3)
- [Imagilin Technology Llc](https://www.keypedia.com/companies/imagilin-technology-llc/4c15c8b6-40cf-4f8e-b970-c0744fc9b8fe)
- [Spinal Resources, Inc.](https://www.keypedia.com/companies/spinal-resources-inc/a6bc95f7-63ca-4ce6-bc11-784efa83bada)
- [Mendell Inc](https://www.keypedia.com/companies/mendell-inc/41f1a305-5b74-428b-a432-0a29801a25f9)
- [Taylor Farms Maryland, Inc.](https://www.keypedia.com/companies/taylor-farms-maryland-inc/5acbab7a-e3c4-4473-a95e-78baadd0d461)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/kara-a-scheibner/63643a3f-4a8e-4dcc-8f1a-6fcf98519aad)
- [Hasan A. Irier](https://www.keypedia.com/people/hasan-a-irier/8757c2d5-77b0-45a7-b0f2-e42ef3ee306f)
- [Arindam Dasgupta, Ph.D., Div. Director (Acting)](https://www.keypedia.com/people/arindam-dasgupta-phd-div-director-acting/a8348132-0b97-4bec-bfd9-e1cbc7fa37c8)
- [Courtney N. Long, Investigator](https://www.keypedia.com/people/courtney-n-long-investigator/0d1ea4e9-f349-43f5-a536-7e0686374010)